Latest news with #RisingStarAwards
Associated Press
5 days ago
- Business
- Associated Press
Multiple Winners at the 2025 Rising Star Awards
Plenty of excitement in our London office this morning on the back of the fantastic news that we have three award winners (our most ever) in the 2025 Rising Star Awards by prestigious awards spotlight the achievements of trailblazing women below senior leadership level and those who inspire the next generation. With over 1000 nominees this year across 20 industries the calibre of entries was truly exceptional and with that we are proud to announce our winners… Amy Firkin - Rising Star 2025 in ESG Navreet Kaur - Rising Star 2025 in Digital Supriya Davda - Rising Star 2025 in HR & RecruitmentWe would also like to highlight both Elena Koycheva, CFA, CAIA, CIPM who was shortlisted for the Rising Star award in ESG and to Dimuthu Ratnayake for getting shortlisted in the Men for Gender Balance category. Visit 3BL Media to see more multimedia and stories from Northern Trust
Yahoo
14-05-2025
- Health
- Yahoo
Noted Vaccine Researcher and Leader Kate O'Brien Awarded Sabin's Gold Medal; Physician Livancliff Mbianke of Cameroon Receives Rising Star Award
Sabin Vaccine Institute Presents 2025 Albert B. Sabin Gold Medal & Rising Star Awards WASHINGTON, May 13, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute today awarded the Albert B. Sabin Gold Medal to pediatrician Katherine O'Brien, MD, MPH, for her research on the pneumococcal vaccine and leadership in global vaccine research and access, and its Rising Star Award to dedicated physician and public health specialist Livancliff Mbianke, MD, MPH, of Cameroon. The awards were presented at a ceremony in the National Academy of Sciences building in Washington D.C. O'Brien is a pioneering global health leader whose innovative work in vaccine access and policy has transformed immunization programs worldwide. 'I am honored to award the Sabin Gold Medal to Dr. O'Brien for her extensive scientific and humanitarian work, which has significantly contributed to the development, licensure, and global distribution of critical immunizations,' says Amy Finan, Sabin's chief executive officer. 'The breadth and scope of her work — in addition to her leadership in advancing the availability of vaccines for everyone, everywhere — has saved millions of lives around the world.' O'Brien's interest in vaccines and preventable illness began during her early career as a research pediatrician in Port-au-Prince, Haiti, where almost a third of children admitted to the hospital she worked at died, often from vaccine-preventable diseases. Returning to the U.S. to pursue her infectious disease fellowship, Master of Public Health, and training as an epidemiologist, she then worked for the Johns Hopkins Center for American Indian Health and led groundbreaking clinical trials on the pneumococcal vaccine to establish the vaccine's performance and impact on both disease and on colonization to achieve both individual and population-level protection. O'Brien was appointed Director of Infectious Disease at the Center and led research on vaccine development and implementation for vaccine-preventable diseases disproportionately affecting Indigenous populations. Her work in large-scale vaccine impact studies and clinical trials has been instrumental in the licensure, introduction and global use of vaccines against pneumococcal disease, rotavirus, influenza, and respiratory syncytial virus (RSV)..O'Brien continued her leadership in vaccine development, access, and research in her position as the Executive Director of the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health. She has served on WHO's Strategic Advisory Group of Experts on Immunization (SAGE) and on the board of Gavi, the Vaccine Alliance, where she has influenced vaccine financing, policy development, and global immunization strategies. In her current role as Director, Immunization, Vaccines and Biologicals for the World Health Organization (WHO), O'Brien leads the global vaccine and immunization strategy. She oversees WHO's work across the vaccine continuum by accelerating new vaccine research and development, advancing vaccine access and equity, introducing new vaccines into country programs, identifying and responding to outbreaks including as WHO's vaccine technical lead during the COVID-19 pandemic, and strengthening immunization program reach in order to maximize the impact of vaccines, even in the most fragile and vulnerable settings. O'Brien earned her medical degree from McGill University and a Master of Public Health from Johns Hopkins University. She completed her pediatric and infectious disease training at Johns Hopkins Medical Institutions and served as an Epidemic Intelligence Service officer at the U.S. Centers for Disease Control and Prevention (CDC). 'I am deeply grateful for a career working with incredible people around the world, and through them to have life-saving impact,' says O'Brien. 'Vaccines are truly one of science's greatest achievements. It is immensely fulfilling to work on vaccines all the way from development through licensure and dissemination, and to then see them protect the lives and well-being of families. This award is a huge honor, and a tribute to those who have taught me the value of evidence-based courage.' Sabin's Rising Star Award is intended to encourage and recognize the next generation of vaccine and immunization leaders. Mbianke is a dedicated physician and public health specialist whose work in vaccine access and strengthening health systems has made a profound impact on underserved communities. With expertise in immunization, maternal and child health, and community engagement, Mbianke has played a pivotal role in expanding vaccine coverage and improving health outcomes in Cameroon. 'With his recognized achievements in reducing maternal and child mortality by 50% in remote areas and increasing accessibility of vaccines, Dr. Mbianke is leading innovations around immunization in fragile settings,' says Finan. 'Whether he is delivering vaccines to displaced populations or creating health clinics out of village councils, his creative solutions serve as a model for those working in challenging settings and makes him a Rising Star in global health.' As Program Country Manager for the COMBAT Project (Community-Based Tracking for Immunization) at the International Vaccine Access Center (IVAC), Mbianke leads efforts to enhance immunization delivery by improving community-based monitoring, engagement, and service delivery strategies. He also serves as Technical Advisor for the World Health Organization's 'Big Catch-Up,' a global initiative aimed at restoring vaccine coverage following pandemic-related disruptions. Beyond his advisory roles, Mbianke is the CEO of Empower Women Foundation, where he champions maternal and child health initiatives in Cameroon, advocating for sustainable and locally driven health care solutions. His leadership extends to past roles with WHO, Gavi, USAID, and other global health organizations, where he has contributed to immunization policy formulation and innovative strategies to reach zero-dose and under-immunized children. A graduate of Université de la Montagne Bagante (MD) and Mountain University for Sustainable Studies (MPH), Mbianke combines medical expertise with public health leadership to promote vaccine confidence and equitable access. 'This award is so meaningful,' says Mbianke. 'When you work in settings with such a high burden, sometimes you feel you are not doing enough because you want to improve as many lives as possible. But recognition like the Rising Star award really motivates you. It says you are creating an impact. You are creating a change.' Awarded annually since 1993 and 2020 respectively, the Albert B. Sabin Gold Medal and Rising Star Award honor individuals who have made extraordinary contributions to immunization and global health. These awards commemorate the legacy of the late Dr. Albert B. Sabin, who discovered the oral polio vaccine and dedicated his life to ensuring everyone in the world had access to vaccines. Watch the 2025 Albert B. Sabin Gold Medal and Rising Star ceremony on Sabin's YouTube channel. About the Sabin Vaccine Institute The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non-profit with three decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit and follow us on X @SabinVaccine. Media Contact: Monika Guttman Senior Media Relations SpecialistSabin Vaccine Institute+1 (202) 621-1691press@ A photo accompanying this announcement is available at
Associated Press
18-04-2025
- Business
- Associated Press
One Mind's Rising Star Awards Celebrates 20 Years of Funding Innovative Mental Health Research
RUTHERFORD, Calif.--(BUSINESS WIRE)--Apr 18, 2025-- One Mind is now actively accepting applications for the 2025 One Mind Rising Star Awards program. Since its founding, One Mind has supported the curiosity and drive of the most promising early career scientists, enabling stunning breakthroughs and launching their careers as leaders. In 2005, One Mind formalized this strategy, launching the Rising Star Awards program with the fundamental belief that investing in world-class early-career investigators pursuing innovative, high-risk, high-reward research would accelerate breakthroughs in mental health conditions and psychiatric disorders. This year, in celebration of its 20th anniversary, One Mind will award at least three Rising Star Awards, each providing a $300,000 research grant ($100,000 per year for three years). This press release features multimedia. View the full release here: Applications for the One Mind Rising Star Awards are now open. Apply today! Over the last two decades, One Mind has awarded over $13 million to 48 Rising Star Awardees pushing the frontiers of mental health science through their research and leadership. Among our 48 Awardees are such luminaries as: One Mind is honored to continue this tradition of supporting great science that is already making an impact on the lives of many. As a 501(c)3 nonprofit, One Mind receives generous philanthropic support from private donors, foundations, and corporate sponsors who make the One Mind Rising Star Awards possible. This year, with generous support from Bristol Myers Squibb and Burroughs Wellcome Fund, one awardee will receive the 'One Mind Bristol Myers Squibb Rising Star Award' and two awardees will receive the 'One Mind Burroughs Wellcome Fund Rising Star Award.' In addition to the $300,000 research grant, this year's Awardees will gain exclusive access to the Rising Leaders Lab, a program designed to equip them with the skills, network, and opportunities to drive meaningful impact in neuroscience research and mental health. Through leadership training, networking, and executive coaching, they will develop expertise in media engagement, negotiation, communication, personal branding, and impactful leadership. Workshops, webinars, and one-on-one mentorship with subject-matter experts will further empower them to become thought leaders shaping the future of mental health. The 2025 One Mind Rising Star Awards will support grant proposals spanning basic/preclinical, translational, and clinical research for psychiatric disorders. These include, but are not limited to, schizophrenia, bipolar disorder, depression, obsessive-compulsive disorder, eating disorders, post-traumatic stress disorder, anxiety disorders, and suicidality. Transdiagnostic investigations and research that bring us closer to precision psychiatry will be given special attention. Illustrative examples include metabolomics biomarkers, gut microbiome-brain interactions, psychedelics, closed-loop neurostimulation, (AI/ML)-based biomarkers, and predictive analytics-based models for evaluating risk or treatment efficacy. Awardees will be selected through a rigorous evaluation process based on the scientific rigor, potential for impact, relevance, feasibility, and innovation of the proposed project, as well as the candidate's credentials, research productivity, and leadership potential. Applications are now open! For more information, and to apply, visit our website at If you are interested in supporting an award, please contact One Mind Chief Development Officer, Tal Gerzon, at [email protected]. About One Mind™ One Mind is at the forefront of a transformative movement in mental health, delivering innovative solutions to address critical gaps in mental health research, care, workplace wellness, and public perception. Guided by science and lived experience, we fund groundbreaking research, accelerate innovation, enhance workplace wellness, and engage the public to reshape mental health care and awareness. With science as our cornerstone, and people at the heart of what we do, our programs are setting new standards for effective interventions and redefining the future of mental health. View source version on One Mind,[email protected] KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: NEUROLOGY MENTAL HEALTH HEALTH SCIENCE RESEARCH SOURCE: One Mind Copyright Business Wire 2025. PUB: 04/18/2025 09:05 AM/DISC: 04/18/2025 09:06 AM
Yahoo
17-04-2025
- Business
- Yahoo
Hermès Sales Growth Slows to 7.2 Percent in Q1
PARIS – Amid the luxury slowdown, Hermès International showed continued strength with sales in the first quarter up 7 percent at constant exchange rates to 4.13 billion euros. The numbers fell slightly short of analysts' expectations, which had forecast the gain at 8 percent to 4.2 billion. More from WWD Trump's Press Secretary's Dress Stirs Up Social Media in China Fashion Group International Presents Rising Star Awards to Bonnie Young, Natalia Fedner, Rex Shoes and More Brunello Cucinelli Posts Growth in Q1, Cites Solid Upward Trend in April While Hermès has outpaced its French luxury rivals such as LVMH Moët Hennessy Louis Vuitton, which reported sales down 2 percent on Monday, it marks a deceleration from the fourth quarter, when the company's sales grew 18 percent. 'In a complex geopolitical and economic context, the house is strengthening its fundamentals more than ever,' Hermès chief executive officer Axel Dumas said in a statement. 'Despite a high comparison basis in the first quarter, the group achieved solid growth in sales.' He highlighted the group's vertically integrated model as one of its core strengths. The result 'confirms a slower consumer demand environment,' Bernstein analyst Luca Solca wrote in a research note. The U.S. showed robustness, up 11 percent at constant exchange, particularly 'solid momentum' in March, even as tariff uncertainty gripped the market. Sales in Europe were up 13 percent, excluding France. Hermès' home country showed robust numbers of 14 percent growth, which the company chalked up to 'sustained local demand and dynamic tourist flows.' The Middle East continued to gain momentum, up 14 percent at constant currency, while Japan saw sales jump 17 percent in the quarter, driven by local clients. The rest of Asia proved to be the weakest point, with sales up just one percent on the continued weakness of China. For the leather goods division, sales at constant currency were up 10 percent, boosted by the new bag designs Médor and Mousqueton, while sales of its ready-to-wear continued to be a dark horse in the house, up 7 percent in the quarter. Silk and textiles, which includes the house's famous scarves, were up 5 percent, while jewelry was up 6 percent. Sales in the fragrance and beauty division were flat. Watches were the weakest link, with the category down 10 percent in the quarter, despite the introduction of two new models during the Watches and Wonders fair in Geneva, and updated version of its classic H08. The company is continuing its expansion, and will open three new production facilities in France over the next three years. Sales were up 9 percent with currency fluctuations taken into account, which boosted the company's bottom line by 49 million euros in revenue. 'In the medium-term, despite the economic, geopolitical and monetary uncertainties around the world, the group confirms an ambitious goal for revenue growth at constant exchange rates,' the company said in a statement. 'In a more uncertain economic and geopolitical context, the group has moved into 2025 with confidence, thanks to the highly integrated artisanal model, the balanced distribution network, the creativity of collections and the loyalty of clients.' Best of WWD Harvey Nichols Sees Sales Dip, Losses Widen in Year Marred by Closures Nike Logs $1.3 Billion Profit, But Supply Chain Issues Persist Zegna Shares Start Trading on New York Stock Exchange
Associated Press
07-03-2025
- Business
- Associated Press
Fashion Group International Announces Finalists for Prestigious Rising Star Awards and Nominates Designer Guillermo Pharis
Celebrating Innovation and Excellence, FGI Recognizes Emerging Talent in its 29th edition. NEW YORK CITY, NEW YORK / ACCESS Newswire / March 7, 2025 / The Fashion Group International (FGI) New York has officially announced the nominees for their highly anticipated annual Rising Star Awards. Among the talented group of designers, one name has been capturing bridal editors and exclusive buyers attention - Guillermo Pharis, a nominee and finalist rising star in the bridal Group International Nominates Guillermo Pharis for Rising Star Awards 2025 Fashion Group International Nominates Guillermo Pharis for Rising Star Awards 2025 Guillermo Pharis, a growing name in the bridal industry, is an American-Honduran designer who launched his first bridal collection few weeks before Covid-19 global pandemic. While so many brands were closing doors, he was trying to build a name for himself in a time where it was almost impossible to navigate the day to day. His nomination for the Rising Star Awards 2025 is a testimony to his talent, perseverance and dedication to the industry. The awards, which recognize emerging talent in various categories of the fashion industry, have become a prestigious honor for up-and-coming designers. The Rising Star Awards, now in its 29th edition, is a highly anticipated event in the fashion industry. The awards ceremony, which will take place on April 16th, 2025 in New York City, will bring together industry leaders to celebrate the nominees and winners. This year's event will be hosted by Tiffany Haddish and the winners in each of the categories will be presented by a wide range of industry figures including Fern Mallis, Gary Wassner, Ken Downing and Reem Acra. The event will feature a cocktail reception followed by a luncheon, and awards presentation. Designer Guillermo Pharis has successfully carved a niche in the bridal-wear industry with his unique blend of timeless and fashion-forward design. By targeting a discerning market and offering personalized service, he has created a strong brand identity and achieved significant success. With strategic locations in major cities, his business is positioned for continued growth and leadership in the wedding dress market. The Fashion Group International is a global, non-profit, professional organization founded in 1930 in New York City to benefit the fashion industry. FGI currently has over 5000 members in the fashion industry including apparel, accessories, beauty and home. The organization is dedicated to fostering creativity and innovation in fashion and is thrilled to announce all the finalists for this year's awards. For more information on the Rising Star Awards Winners visit their website at To Learn more about the collections of FGI Rising Star Finalist Guillermo Pharis visit the online store
